BRKR

Bruker Corporation (BRKR)

Wednesday, November 4, 2026
Past 1Y
MA21MA180
Signals
BuyEarly buySellEarly sellTurning points
Swing highSwing low
Up dayDown day

Bruker (BRKR) at a glance

Close · Aug 4, 2026
$50.30
Day change
-21.79%
52-week range
$32.29 – $65.30
Market cap
$8.6B
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ

Bruker stock: what the data says

Bruker (BRKR) closed at $50.30 on Aug 4, 2026, down 21.8% on the day. The stock is down 18.0% over the past month, up 38.3% over three months, up 7.0% year to date and up 45.6% over the past year (since Aug 4, 2025). It trades 23.0% below its 52-week high of $65.30 and 55.8% above its 52-week low of $32.29. The close sits below its 50-day moving average ($58.05) and above its 200-day moving average ($45.91).

BRKR is scheduled to report earnings on Nov 4, 2026, before market open.

BRKR earnings

Next report
Nov 4, 2026, before market open
Earnings quality grade
B(report of Nov 4, 2026)

BRKR earnings analysis →

BRKR stock: key questions

When is BRKR's next earnings date?

Bruker is scheduled to report on Nov 4, 2026, before market open.

Is BRKR above its 200-day moving average?

Yes — the Aug 4, 2026 close of $50.30 is 9.6% above the 200-day average of $45.91.

How far is BRKR from its 52-week high?

BRKR closed 23.0% below its 52-week high of $65.30.

About Bruker Corporation

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.

bruker.com